Search Results 331-340 of 17850 for Coagulate

1. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

   Active disseminated intravascular coagulation (DIC); Active central nervous system (CNS) leukemia; Active, uncontrolled infection; patients with infection ...

2. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   Coagulation; International normalized ratio (INR) OR prothrombin time (PT); Activated partial thromboplastin time (aPTT) ≤1.5 × ULN unless participant is ...

3. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

   ... coagulation as prophylaxis if they are not currently on full-dose anticoagulation. Patients with a history of chronic obstructive pulmonary disease (COPD) ...

4. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial - Mayo Clinic

   Contraindication to appropriate anti-coagulation therapy; Renal failure requiring dialysis; Medical conditions limiting expected survival to <1 year; Women of ...

5. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   Laboratory results (serum chemistry, hematology, coagulation and urinalysis) outside the normal range at Screening and Check-In and considered clinically ...

6. A Study to Analyze the Effects of Exparel for Post-Surgery Pain Control in Patients Undergoing Penile Prosthesis Placement - Mayo Clinic

   Current anti-platelet or anti-coagulation therapy with plans to continue at the time of prosthesis placement. Poorly controlled diabetes mellitus (defined ...

7. A Platform Study In Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   \- Adequate coagulation and urinalysis. Exclusion Criteria (both sub study 1 and sub study 2): * Participants with epidermal growth factor receptor ...

8. Study of AMG 650 in Adult Participants With Advanced Solid Tumors - Mayo Clinic

   Adequate coagulation laboratory assessments, as follows: Prothrombin time (PT) or activated partial thromboplastin time (APTT) < 1.5 x upper limit of normal ...

9. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   Screening values of coagulation parameters including platelet count ... Taking anticoagulant medication (warfarin, heparinoids, and direct coagulation ...

10. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    ... coagulation. In the Phase 2 portion of the trial only, subjects who have previously received treatment with an inhibitor of Isocitrate dehydrogenase protein ...